Umbilical cord blood transplant

Umbilical cord blood transplant: An umbilical cord blood transplant is the transfusion of healthy stem cells from a baby's umbilical cord into the same person (autogenic transplant) years later as a treatment for a weakened or abnormal immune system due to radiation or chemotherapy or with certain blood cancers. The cord blood may also be used in another individual (allogenic transplant). The cord blood consists of stem cells that differentiate into mature blood cells that fight infection and disease.

Diseases And Conditions Treated: Umbilical cord blood transplant

These diseases and conditions may be treated with the surgical procedure Umbilical cord blood transplant:

Hodgkin's lymphoma
Non-Hodgkin's lymphoma
Ewing sarcoma
Neuroblastoma
Rhabdomyosarcoma
Thymoma (thymus cancer)
Bone marrow disorder (e.g. anemia)
Histiocystic disorders (abnormal accumulation of histiocytes in the body)
Leukemia
Multiple myeloma
Amyloidosis
Lesch-Nyhan syndrome
Adrenoleukodystrophy
Congenital neutropenia
Wiskott-Aldrich syndrome
X-linked lymphoproliferative disorder
Congenital erythropoietic porphyria
DiGeorge syndrome
Osteopetrosis
Chronic active Epstein Barr virus
Sickle cell anemia
Aplastic anemia
Thalassemia
Severe combined immunodeficiency syndromes
Bone marrow destroyed by radiation or chemotherapy

Anesthetic Requirements for Umbilical cord blood transplant

These surgical anesthetic requirements for the procedure Umbilical cord blood transplant may include:

Local anesthesia

Procedure Complications: Umbilical cord blood transplant

Possible surgical complications of Umbilical cord blood transplant may include:

Pain
Nausea
Fever
Headache
Low blood pressure
Chest pain
Infection
Bleeding
Organ damage
Transplant rejection
Growth delay (in children)

Prognosis for a Good Outcome: Umbilical cord blood transplant

The prognosis for a good medical outcome: The prognosis is highly variable.